Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M A Polis

Showing results (51-60 of 71) with videos related to

Pageof 8
Sort By:
The Journal of Infectious Diseases|April 1, 1996
Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: results of a phase I/II trialJ A Kovacs, C Bechtel, R T Davey, et al.
The Journal of Infectious Diseases|September 9, 2000
Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expressionJ A Kovacs, H Imamichi, S Vogel, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infectionM A Polis, S C Piscitelli, S Vogel, et al.
AIDS (London, England)|November 24, 1999
Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patientJ M Orenstein, M Feinberg, C Yoder, et al.
Journal of Blood & Lymph|February 10, 2018
Establishing Reference Ranges of Hematological Parameters from Malian Healthy AdultsB Kone, M Maiga, B Baya, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 18, 2012
Molecular strain typing of Mycobacterium tuberculosis complex in Bamako, MaliB Traore, B Diarra, B P P Dembele, et al.
The Journal of Infectious Diseases|March 9, 1999
A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infectionR T Davey, D G Chaitt, J M Albert, et al.
Nature|January 1, 1999
Changes in thymic function with age and during the treatment of HIV infectionD C Douek, R D McFarland, P H Keiser, et al.
European Journal of Immunology|July 24, 2001
Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapyJ A Kovacs, S Vogel, J A Metcalf, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2000
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patientsR A Lempicki, J A Kovacs, M W Baseler, et al.
Pageof 8

Showing results (51-60 of 71) with videos related to

Sort By:
Pageof 8
The Journal of Infectious Diseases|April 1, 1996
Combination therapy with didanosine and interferon-alpha in human immunodeficiency virus-infected patients: results of a phase I/II trialJ A Kovacs, C Bechtel, R T Davey, et al.
The Journal of Infectious Diseases|September 9, 2000
Effects of intermittent interleukin-2 therapy on plasma and tissue human immunodeficiency virus levels and quasi-species expressionJ A Kovacs, H Imamichi, S Vogel, et al.
Antimicrobial Agents and Chemotherapy|August 1, 1997
Clarithromycin lowers plasma zidovudine levels in persons with human immunodeficiency virus infectionM A Polis, S C Piscitelli, S Vogel, et al.
AIDS (London, England)|November 24, 1999
Lymph node architecture preceding and following 6 months of potent antiviral therapy: follicular hyperplasia persists in parallel with p24 antigen restoration after involution and CD4 cell depletion in an AIDS patientJ M Orenstein, M Feinberg, C Yoder, et al.
Journal of Blood & Lymph|February 10, 2018
Establishing Reference Ranges of Hematological Parameters from Malian Healthy AdultsB Kone, M Maiga, B Baya, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|April 18, 2012
Molecular strain typing of Mycobacterium tuberculosis complex in Bamako, MaliB Traore, B Diarra, B P P Dembele, et al.
The Journal of Infectious Diseases|March 9, 1999
A randomized trial of high- versus low-dose subcutaneous interleukin-2 outpatient therapy for early human immunodeficiency virus type 1 infectionR T Davey, D G Chaitt, J M Albert, et al.
Nature|January 1, 1999
Changes in thymic function with age and during the treatment of HIV infectionD C Douek, R D McFarland, P H Keiser, et al.
European Journal of Immunology|July 24, 2001
Interleukin-2 induced immune effects in human immunodeficiency virus-infected patients receiving intermittent interleukin-2 immunotherapyJ A Kovacs, S Vogel, J A Metcalf, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 30, 2000
Impact of HIV-1 infection and highly active antiretroviral therapy on the kinetics of CD4+ and CD8+ T cell turnover in HIV-infected patientsR A Lempicki, J A Kovacs, M W Baseler, et al.
Pageof 8